Results 131 to 140 of about 207,054 (311)

Combating VEGFA‐siRNA‐Induced Metabolic Reprogramming via Glucose Utilization Deprivation

open access: yesAdvanced Science, EarlyView.
An ionizable lipid nanoparticle co‐delivers VEGFA siRNA and glucose oxidase to tumors to counteract VEGFA knockdown‐induced, glutamine‐driven metabolic compensation. Enzymatic glucose consumption reverses the adaptive pathways and restores metabolism toward baseline, thereby sensitizing tumors to therapy.
Lulu Zheng   +10 more
wiley   +1 more source

Functional Mapping of Neurodevelopmental Disease Pathways to Key Neurodevelopmental Processes Represented in the Developmental Neurotoxicity In Vitro Testing Battery

open access: yesAdvanced Science, EarlyView.
Human‐relevant methods are essential for modern chemical safety assessment. This study helps define the capabilities and boundaries of an in vitro testing battery for developmental neurotoxicity by exploring its biological applicability domain. By linking neurodevelopmental disease‐related pathways to key neurodevelopmental processes, the work enhances
Eliska Kuchovska   +14 more
wiley   +1 more source

Intranuclear localization of phospholipids by ultrastructural cytochemistry.

open access: yes, 1992
The presence of phospholipids within the interphase nucleus and in isolated chromatin, previously demonstrated by analytical biochemical methods, has been only rarely documented by cytochemical procedures, especially at the ultrastructural level.
N M Maraldi   +5 more
core   +1 more source

PHOSPHOLIPIDS. PHYSICOCHEMICAL PROPERTIES OF PHOSPHOLIPIDS

open access: yes
The article discusses the composition and physical and chemical properties of phospholipids and the study of the chemical composition of phospholipids. It also discusses the development of methods for identifying and establishing the chemical composition of phospholipids.
Tashmukhamedova, Shohista   +1 more
openaire   +1 more source

NUP85 Mediates Endoplasmic Reticulum Stress through the USP47/ASK1 Signaling Pathway to Regulate the Progression of Liver Fibrosis

open access: yesAdvanced Science, EarlyView.
In the present study, we have demonstrated that the NUP85‐USP47‐ASK1 signaling pathway may have regulated the progression of liver fibrosis through modulating ERS. Additionally, we have developed a CREKA‐coupled liposome to target delivery of MV, a pharmacological inhibitor of NUP85, to activated HSCs, thereby attenuating liver fibrosis. ABSTRACT Liver
Dashuai Yang   +11 more
wiley   +1 more source

Self-assembly lipid-based nanoparticles containing zoledronic acid: a new strategy for the treatment of cancer

open access: yes, 2011
Introduction: Zoledronic acid (ZOL), a third generation amino-bisphosphonate (A-BP), is actually, the most potent inhibitor of the bone resorption, largely used in clinic for the treatment of bone diseases (i.e.
C. Leonetti   +8 more
core  

Synthetic scheme for the phospholipids.

open access: yes, 2015
Synthetic scheme for the phospholipids.
Ying Sun (23237)   +5 more
core   +1 more source

Emulsions stabilized by phospholipids

open access: yesJournal of Colloid and Interface Science
Phospholipids are amphiphilic molecules able to adsorb at oil/water interfaces and thus used to stabilize parenteral emulsions. Yet, their low preferred curvature, which sensitively depends on molecular structures and interactions, favors the formation of lamellar phases and sets constraints on the system formulation.
Jenny Marie Andersson   +2 more
openaire   +2 more sources

Androgen Receptor‐Induced Lactoferrin Accelerates Prostate Tumorigenesis Through Modulating Ferroptosis

open access: yesAdvanced Science, EarlyView.
This study demonstrates that transcription factor androgen receptor (AR) directly binds the LF promoter, driving lactoferrin overexpression to promote ferritin (FTH1/FTL) upregulation and inhibit p53‐ALOX12‐mediated ferroptosis in prostate cancer. Lactoferrin could be a new potential therapeutic target in prostate cancer.
Can Liu   +18 more
wiley   +1 more source

Structures of synthesized isoprenoid phospholipids.

open access: yes, 2017
Structures of synthesized isoprenoid phospholipids.
Anna Gliszczyńska (2839163)   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy